CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
0.9967
0.31%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0031
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023374 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023374%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001151 %
Charges from full value of position ($0.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001151%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.9936
Open 0.9957
1-Year Change -67.03%
Day's Range 0.9956 - 0.9971
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 0.9967 0.0010 0.10% 0.9957 0.9971 0.9956
Sep 28, 2023 0.9936 0.0010 0.10% 0.9926 0.9971 0.9915
Sep 27, 2023 0.9916 0.0015 0.15% 0.9901 0.9919 0.9901
Sep 26, 2023 0.9915 0.0008 0.08% 0.9907 0.9919 0.9901
Sep 25, 2023 0.9909 0.0021 0.21% 0.9888 0.9953 0.9888
Sep 22, 2023 0.9890 0.0003 0.03% 0.9887 0.9892 0.9866
Sep 21, 2023 0.9886 -0.0001 -0.01% 0.9887 0.9943 0.9861
Sep 20, 2023 0.9887 0.0000 0.00% 0.9887 0.9902 0.9885
Sep 19, 2023 0.9887 0.0041 0.42% 0.9846 0.9899 0.9845
Sep 18, 2023 0.9847 0.0011 0.11% 0.9836 0.9946 0.9836
Sep 15, 2023 0.9857 0.0021 0.21% 0.9836 0.9913 0.9819
Sep 14, 2023 0.9817 0.0000 0.00% 0.9817 0.9838 0.9816
Sep 13, 2023 0.9818 0.0002 0.02% 0.9816 0.9873 0.9807
Sep 12, 2023 0.9820 -0.0016 -0.16% 0.9836 0.9836 0.9797
Sep 11, 2023 0.9804 -0.0012 -0.12% 0.9816 0.9840 0.9796
Sep 8, 2023 0.9811 -0.0007 -0.07% 0.9818 0.9838 0.9806
Sep 7, 2023 0.9818 0.0007 0.07% 0.9811 0.9839 0.9807
Sep 6, 2023 0.9827 0.0041 0.42% 0.9786 0.9851 0.9786
Sep 5, 2023 0.9806 0.0128 1.32% 0.9678 0.9883 0.9593
Sep 1, 2023 0.9687 0.0100 1.04% 0.9587 0.9741 0.9587

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Berkeley Lights, Inc. Company profile

About Berkeley Lights Inc

Berkeley Lights, Inc. is a digital cell biology company. The Company is focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Company's Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Berkeley Lights platform is a fully integrated, end-to-end solution, consisting of consumables, including its OptoSelect chips and reagent kits, advanced automation systems, and advanced application and workflow software. The Company's platform leverages its OptoElectro Positioning (OEP) technology, which provides deterministic positioning of living single cells and other micro-objects using light. The Company's software products include Cell Analysis Suite (CAS), Workflow Runner/Builder, Assay Analyzer, Image Analyzer, and PrimeSeq.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Berkeley Lights Inc revenues increased 33% to $85.4M. Net loss applicable to common stockholders increased 66% to $71.7M. Revenues reflect Antibody Therapeutics segment increase of 24% to $64.3M, Synthetic Biology segment increase of 11% to $9M, Asia Pacific segment increase of 82% to $35.2M, North America segment increase of 27% to $41.2M.

Industry: Biotechnology & Medical Research (NEC)

5858 Horton Street
Suite 320
EMERYVILLE
CALIFORNIA 94608
US

People also watch

ETH/USD

3,326.39 Price
+0.300% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,269.40 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

XRP/USD

2.25 Price
+0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01120

Gold

2,623.59 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0151%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading